Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Subjects With Moderately Active Rheumatoid Arthritis Despite DMARD Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Hydroxychloroquine; Leflunomide; Methotrexate; Minocycline; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Amgen
- 27 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Mar 2013 Planned end date changed from 1 Apr 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.